AnishBadwe

200 EMA Crossover repeating itself + Great earnings expectations

Long
AnishBadwe Updated   
NASDAQ:AVXL   Anavex Life Sciences Corp.
The 200 EMA crossover has occurred again! This time we have positive expectations of earnings as well. A good recipe for gains.
Keeping the analysis simple.

Target price: 3.5+
Comment:
Stop has been placed at 2.61, below the downtrend's low.
Comment:
Things not looking good as AVXL failed to hold above the 200 EMA for a second time.
Trade closed: stop reached
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.